Content for the panel was based on assessment of genes with differential expression between breast cancer cell lines of known subtypes, published reports of proliferation markers, and genes associated with epithelial-mesenchymal transition and PI3K pathway signaling [9], [19]. The gene discussed is PIK3CA; the disease is breast carcinoma.